Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

In situ delivery of passive immunity by lactobacilli producing single-chain antibodies

Abstract

Lactobacilli have previously been used to deliver vaccine components for active immunization in vivo. Vectors encoding a single-chain Fv (scFv) antibody fragment, which recognizes the streptococcal antigen I/II (SAI/II) adhesion molecule of Streptococcus mutans, were constructed and expressed in Lactobacillus zeae (American Type Culture Collection (ATCC) 393). The scFv antibody fragments secreted into the supernatant or expressed on the surface of the bacteria showed binding activity against SAI/II in enzyme-linked immunosorbent assay (ELISA), and surface scFv-expressing lactobacilli agglutinated SAI/II-expressing S. mutans in vitro without affecting the corresponding SAI/II knockout strain. Lactobacilli expressing the scFv fragment fused to an E-tag were visualized by scanning electron microscopy (SEM) using beads coated with a monoclonal anti-E-tag antibody, and they bound directly to beads coated with SAI/II. After administration of scFv-expressing bacteria to a rat model of dental caries development, S. mutans bacteria counts and caries scores were markedly reduced. As lactobacilli are generally regarded as safe (GRAS) microorganisms, this approach may be of considerable commercial interest for in vivo immunotherapy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Map of Lactobacillus expression vectors.
Figure 2: Detection of the scFv expressed by L. zeae by immunoblotting and fluorescence-activated cell sorting (FACS).
Figure 3: Adherence of transformed lactobacilli to magnetic beads coated with E-tag antibodies or SAI/II.

Similar content being viewed by others

References

  1. Krasse, B., Edwardsson, S., Svensson, I. & Trell, L. Implantation of caries-inducing streptococci in the human oral cavity. Arch. Oral Biol. 12, 231–236 (1967).

    Article  CAS  Google Scholar 

  2. Krasse, B. & Carlsson, J. Various types of streptococci and experimental caries in hamsters. Arch. Oral Biol. 15, 25–32 (1970).

    Article  CAS  Google Scholar 

  3. Lehner, T., Challacombe, S.J. & Caldwell, J. Immunologic basis for vaccination against dental caries in rhesus monkeys. J. Dent. Res. 55, C166–C180 (1976).

    Article  Google Scholar 

  4. Loesche, W.J., Rowan, J., Straffon, L.H. & Loos, P.J. Association of Streptococcus mutants with human dental decay. Infect. Immun. 11, 1252–1260 (1975).

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Russell, M.W. Immunization against dental caries. Curr. Opin. Dent. 2, 72–80 (1992).

    CAS  PubMed  Google Scholar 

  6. Loesche, W.J. Role of Streptococcus mutans in human dental decay. Microbiol. Rev. 50, 353–380 (1986).

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Michalek, S.M. et al. Protection of gnotobiotic rats against dental caries by passive immunization with bovine milk antibodies to Streptococcus mutans. Infect. Immun. 55, 2341–2347 (1987).

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Hamada, S. et al. Oral passive immunization against dental caries in rats by use of hen egg yolk antibodies specific for cell-associated glucosyltransferase of Streptococcus mutans. Infect. Immun. 59, 4161–4167 (1991).

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Filler, S.J., Gregory, R.L., Michalek, S.M., Katz, J. & McGhee, J.R. Effect of immune bovine milk on Streptococcus mutans in human dental plaque. Arch. Oral Biol. 36, 41–47 (1991).

    Article  CAS  Google Scholar 

  10. Hatta, H. et al. Passive immunization against dental plaque formation in humans: effect of a mouth rinse containing egg yolk antibodies (IgY) specific to Streptococcus mutans. Caries Res. 31, 268–274 (1997).

    Article  CAS  Google Scholar 

  11. Lehner, T., Caldwell, J. & Smith, R. Local passive immunization by monoclonal antibodies against streptococcal antigen I/II in the prevention of dental caries. Infect. Immun. 50, 796–799 (1985).

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Lehner, T., Ma, J.K. & Kelly, C.G. A mechanism of passive immunization with monoclonal antibodies to a 185,000 M(r) streptococcal antigen. Adv. Exp. Med. Biol. 327, 151–163 (1992).

    Article  CAS  Google Scholar 

  13. Ma, J.K., Smith, R. & Lehner, T. Use of monoclonal antibodies in local passive immunization to prevent colonization of human teeth by Streptococcus mutans. Infect. Immun. 55, 1274–1278 (1987).

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Ma, J.K., Hunjan, M., Smith, R., Kelly, C. & Lehner, T. An investigation into the mechanism of protection by local passive immunization with monoclonal antibodies against Streptococcus mutans. Infect. Immun. 58, 3407–3414 (1990).

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Ma, J.K. et al. Generation and assembly of secretory antibodies in plants. Science 268, 716–719 (1995).

    Article  CAS  Google Scholar 

  16. Ma, J.K. et al. Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat. Med. 4, 601–606 (1998).

    Article  CAS  Google Scholar 

  17. Little, M., Kipriyanov, S.M., Le Gall, F. & Moldenhauer, G. Of mice and men: hybridoma and recombinant antibodies. Immunol. Today 21, 364–370 (2000).

    Article  CAS  Google Scholar 

  18. Lorenzen, N. et al. Immunoprophylaxis in fish by injection of mouse antibody genes. Nat. Biotechnol. 18, 1177–1180 (2000).

    Article  CAS  Google Scholar 

  19. Giddings, G., Allison, G., Brooks, D. & Carter, A. Transgenic plants as factories for biopharmaceuticals. Nat. Biotechnol. 18, 1151–1155 (2000).

    Article  CAS  Google Scholar 

  20. Mottershead, D.G., Alfthan, K., Ojala, K., Takkinen, K. & Oker-Blom, C. Baculoviral display of functional scFv and synthetic IgG-binding domains. Biochem. Biophys. Res. Commun. 275, 84–90 (2000).

    Article  CAS  Google Scholar 

  21. Lamarre, A., Yu, M.W., Chagnon, F. & Talbot, P.J. A recombinant single chain antibody neutralizes coronavirus infectivity but only slightly delays lethal infection of mice. Eur. Immunol. 27, 3447–3455 (1997).

    Article  CAS  Google Scholar 

  22. Magliani, W. et al. Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity. Nat. Biotechnol. 15, 155–158 (1997).

    Article  CAS  Google Scholar 

  23. Matthews, R., Hodgetts, S. & Burnie, J. Preliminary assessment of a human recombinant antibody fragment to hsp90 in murine invasive candidiasis. J. Infect. Dis. 171, 1668–1671 (1995).

    Article  CAS  Google Scholar 

  24. de Vos, W.M. Gene expression systems for lactic acid bacteria. Curr. Opin. Microbiol. 2, 289–295 (1999).

    Article  CAS  Google Scholar 

  25. Ahrne, S. et al. The normal Lactobacillus flora of healthy human rectal and oral mucosa. J. Appl. Microbiol. 85, 88–94 (1998).

    Article  CAS  Google Scholar 

  26. Shornikova, A.V., Casas, I.A., Isolauri, E., Mykkanen, H. & Vesikari, T. Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. J. Pediatr. Gastroenterol. Nutr. 24, 399–404 (1997).

    Article  CAS  Google Scholar 

  27. Gionchetti, P., Rizzello, F., Venturi, A. & Campieri, M. Probiotics in infective diarrhea and inflammatory bowel diseases. J. Gastroenterol. Hepatol. 15, 489–493 (2000).

    Article  CAS  Google Scholar 

  28. Guandalini, S. et al. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J. Pediatr. Gastroenterol. Nutr. 30, 54–60 (2000).

    Article  CAS  Google Scholar 

  29. Vanderhoof, J.A. et al. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J. Pediatr. 135, 564–568 (1999).

    Article  CAS  Google Scholar 

  30. Perdigon, G., de Macias, M.E., Alvarez, S., Oliver, G. & de Ruiz Holgado, A.P. Systemic augmentation of the immune response in mice by feeding fermented milks with Lactobacillus casei and Lactobacillus acidophilus. Immunology 63, 17–23 (1988).

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Isolauri, E., Joensuu, J., Suomalainen, H., Luomala, M. & Vesikari, T. Improved immunogenicity of oral D × RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine 13, 310–312 (1995).

    Article  CAS  Google Scholar 

  32. Pouwels, P.H., Leer, R.J. & Boersma, W.J. The potential of Lactobacillus as a carrier for oral immunization: development and preliminary characterization of vector systems for targeted delivery of antigens. J. Biotechnol. 44, 183–192 (1996).

    Article  CAS  Google Scholar 

  33. Pouwels, P.H. et al. Lactic acid bacteria as antigen delivery vehicles for oral immunization purposes. Int. J. Food Microbiol. 41, 155–167 (1998).

    Article  CAS  Google Scholar 

  34. Shaw, D.M. et al. Engineering the microflora to vaccinate the mucosa: serum immunoglobulin G responses and activated draining cervical lymph nodes following mucosal application of tetanus toxin fragment C-expressing lactobacilli. Immunology 100, 510–518 (2000).

    Article  CAS  Google Scholar 

  35. Pouwels, P.H. et al. Lactobacilli as vehicles for targeting antigens to mucosal tissues by surface exposition of foreign antigens. Methods Enzymol. 336, 369–389 (2001).

    Article  CAS  Google Scholar 

  36. Piard, J.C., Jimenez-Diaz, R., Fischetti, V.A., Ehrlich, S.D. & Gruss, A. The M6 protein of Streptococcus pyogenes and its potential as a tool to anchor biologically active molecules at the surface of lactic acid bacteria. Adv. Exp. Med. Biol. 418, 545–550 (1997).

    Article  CAS  Google Scholar 

  37. Savijoki, K., Kahala, M. & Palva, A. High level heterologous protein production in Lactococcus and Lactobacillus using a new secretion system based on the Lactobacillus brevis S-layer signals. Gene 186, 255–262 (1997).

    Article  CAS  Google Scholar 

  38. Eibl, M.M., Wolf, H.M., Furnkranz, H. & Rosenkranz, A. Prevention of necrotizing enterocolitis in low-birth-weight infants by IgA-IgG feeding. N. Engl. J. Med. 319, 1–7 (1988).

    Article  CAS  Google Scholar 

  39. Tjellström, B., Stenhammar, L., Eriksson, S. & Magnusson, K.E. Oral immunoglobulin A supplement in treatment of Clostridium difficile enteritis. Lancet 341, 701–702 (1993).

    Article  Google Scholar 

  40. Hammarström, V., Smith, C.I. & Hammarström, L. Oral immunoglobulin treatment in Campylobacter jejuni enteritis. Lancet 341, 1036 (1993).

  41. Casswall, T.H. et al. Oral IgA-IgG treatment of chronic non-specific diarrhea in infants and children. Acta. Paediatr. 85, 1126–1128 (1996).

    Article  CAS  Google Scholar 

  42. Weiner, C. et al. Passive immunity against human pathogens using bovine antibodies. Clin. Exp. Immunol. 116, 193–205 (1999).

    Article  CAS  Google Scholar 

  43. Steidler, L. et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289, 1352–1355 (2000).

    Article  CAS  Google Scholar 

  44. Gunneriusson, E., Samuelson, P., Uhlen, M., Nygren, P.A. & Stahl, S. Surface display of a functional single-chain Fv antibody on staphylococci. J. Bacteriol. 178, 1341–1346 (1996).

    Article  CAS  Google Scholar 

  45. Beninati, C. et al. Therapy of mucosal candidiasis by expression of an anti-idiotype in human commensal bacteria. Nat. Biotechnol. 18, 1060–1064 (2000).

    Article  CAS  Google Scholar 

  46. Maassen, C.B. et al. Instruments for oral disease-intervention strategies: recombinant Lactobacillus casei expressing tetanus toxin fragment C for vaccination or myelin proteins for oral tolerance induction in multiple sclerosis. Vaccine 17, 2117–2128 (1999).

    Article  CAS  Google Scholar 

  47. Bleiweis, A.S., Lee, S.F., Brady, L.J., Progulske-Fox, A. & Crowley, P.J. Cloning and inactivation of the gene responsible for a major surface antigen on Streptococcus mutans. Arch. Oral Biol. 35, 15S–23S (1990).

    Article  CAS  Google Scholar 

  48. Bowen, W.H., Pearson, S.K. & Young, D.A. The effect of desalivation on coronal and root surface caries in rats. J. Dent. Res. 67, 21–23 (1988).

    Article  CAS  Google Scholar 

  49. Keyes, P.H. Dental caries in the molar teeth of rats. II. A method for diagnosing and scoring several types of lesions simultaneously. J. Dent. Res. 37, 1088–1099 (1958).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the Swedish Medical Research Council and by the Foundation for Preventive Caries Research (Patentmedelsfonden).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lennart Hammarström.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krüger, C., Hu, Y., Pan, Q. et al. In situ delivery of passive immunity by lactobacilli producing single-chain antibodies. Nat Biotechnol 20, 702–706 (2002). https://doi.org/10.1038/nbt0702-702

Download citation

  • Received:

  • Accepted:

  • Issue date:

  • DOI: https://doi.org/10.1038/nbt0702-702

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing